Clinical characteristics and prognosis of patients with Castleman disease in a Chinese hospital: paraneoplastic pemphigus is an independent risk factor
- PMID: 35273707
- PMCID: PMC8902542
Clinical characteristics and prognosis of patients with Castleman disease in a Chinese hospital: paraneoplastic pemphigus is an independent risk factor
Abstract
Objective: Castleman disease (CD) is a rare lymphoproliferative disorder with limited clinical research data. This study aimed to investigate the clinical manifestations, pathologic features, and prognostic factors of CD.
Methods: The clinicopathological data of 54 patients with CD hospitalized in the First Affiliated Hospital of Nanjing Medical University were retrospectively analyzed. Univariate analysis and multivariate analysis were performed by Cox regression model to determine independent prognostic factors for patients' survival.
Results: According to clinical classification, 30 cases (55.6%) had unicentric CD (UCD) and 24 cases (44.4%) had multicentric CD (MCD). Moreover, pathologic classification revealed 32 cases (59.3%) with hyaline vascular variant, 3 (5.6%) with mixed cellular variant, and 19 (35.2%) with plasmacytic variant. Patients with MCD commonly presented with clinical signs and symptoms, including fever, splenomegaly, and pleural effusion and/or ascites. Clinical complications, such as liver injury, anemia, and polyradiculoneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin changes (POEMS) syndrome were more common in patients with MCD. Univariate analysis showed that the presence of paraneoplastic pemphigus (PNP) and the elevation of C-reactive protein were unfavorable prognosticators of survival in patients with CD. By multivariate analysis PNP was an independent prognostic factor in patients with CD.
Conclusions: This study provided a panoramic elaboration of CD cases and showed that the presence of PNP was an independent unfavorable factor.
Keywords: Castleman disease; paraneoplastic pemphigus; prognostic factors; survival.
AJTR Copyright © 2022.
Conflict of interest statement
None.
Figures


Similar articles
-
Clinical and laboratory characterization of 114 cases of Castleman disease patients from a single centre: paraneoplastic pemphigus is an unfavourable prognostic factor.Br J Haematol. 2015 Jun;169(6):834-42. doi: 10.1111/bjh.13378. Epub 2015 Mar 30. Br J Haematol. 2015. PMID: 25824806
-
Predominant Stroma-Rich Feature in Hyaline Vascular Variant of Castleman Disease Is Associated With Paraneoplastic Pemphigus.Am J Clin Pathol. 2020 Aug 5;154(3):403-413. doi: 10.1093/ajcp/aqaa053. Am J Clin Pathol. 2020. PMID: 32459333
-
Multicentric Castleman disease of hyaline‑vascular variant with paraneoplastic pemphigus results in abnormal lung function: Report of 3 cases.Exp Ther Med. 2023 Apr 20;25(6):269. doi: 10.3892/etm.2023.11968. eCollection 2023 Jun. Exp Ther Med. 2023. PMID: 37206548 Free PMC article.
-
Clinical features and treatment outcomes of Castleman disease in children: a retrospective cohort in China.Eur J Pediatr. 2023 Dec;182(12):5519-5530. doi: 10.1007/s00431-023-05235-2. Epub 2023 Oct 2. Eur J Pediatr. 2023. PMID: 37782352 Free PMC article. Review.
-
Clinicopathological comparison and therapeutic approach to Castleman disease-a case-based review.J Thorac Dis. 2019 Nov;11(11):4859-4874. doi: 10.21037/jtd.2019.10.73. J Thorac Dis. 2019. PMID: 31903277 Free PMC article. Review.
Cited by
-
Exploring castleman disease in a cohort of hispanic patients: a recognition to its histopathology.J Hematop. 2025 May 12;18(1):25. doi: 10.1007/s12308-025-00637-7. J Hematop. 2025. PMID: 40355649
-
Castleman disease coexisting with papillary thyroid carcinoma: A case report.Oncol Lett. 2025 Mar 5;29(5):218. doi: 10.3892/ol.2025.14964. eCollection 2025 May. Oncol Lett. 2025. PMID: 40093870 Free PMC article.
-
Paraneoplastic pemphigus: Diagnostic mimics, confounders and management challenges in a series of five long-term survivors from a single centre.Skin Health Dis. 2022 Dec 19;3(3):e200. doi: 10.1002/ski2.200. eCollection 2023 Jun. Skin Health Dis. 2022. PMID: 37275411 Free PMC article.
References
-
- Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956;9:822–830. - PubMed
-
- Herrada J, Cabanillas F, Rice L, Manning J, Pugh W. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med. 1998;128:657–662. - PubMed
-
- Dong Y, Wang M, Nong L, Wang L, Cen X, Liu W, Zhu S, Sun Y, Liang Z, Li Y, Ou J, Qiu Z, Ren H. Clinical and laboratory characterization of 114 cases of Castleman disease patients from a single centre: paraneoplastic pemphigus is an unfavourable prognostic factor. Br J Haematol. 2015;169:834–842. - PubMed
-
- Cronin DM, Warnke RA. Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol. 2009;16:236–246. - PubMed
-
- Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29:670–683. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous